TORONTO - The use of high potency versions of cholesterol lowering drugs called statins may increase a person's risk of developing kidney failure, a new study suggests. The research found that when compared to low dose statin regimens, high potency versions of the pills were linked to slightly elevated rates of acute kidney injury.
Also On Wellness
Use of high potency cholesterol drugs linked to risk of kidney injury: Study
TORONTO - The use of high potency versions of cholesterol lowering drugs called statins may increase a person's risk of developing kidney failure, a new study suggests. The research found that when compared to low dose statin regimens, high potency versions of the pills were linked to slightly elevated rates of acute kidney injury.
Disclaimer: References or links to other sites from Wellness.com does not constitute recommendation or endorsement by Wellness.com. We bear no responsibility for the content of websites other than Wellness.com.
Community Comments
Be the first to comment.
©2025 Wellness®.com is a registered trademark of Wellness.com, Inc. 